Synergy Health extends presence in Germany
To acquire GSP for €9.5m and add electron beam processing to services
Synergy Health, a provider of sterilisation and infection control services to hospitals, has expanded its European business with the acquisition of Gamma- Service- Produktbestrahlung (GSP) for €9.5m (£8m).
The acquisition of GSP, based near Dresden, Germany will enable Synergy to add electron beam processing to its service offering in mainland Europe. GSP's proximity to Poland and the Czech Republic will also provides Synergy with a route to enter other markets in Eastern Europe, the company said.
GSP provides both gamma and e-beam sterilisation services to the healthcare and industrial sectors. Sales in 2009 were €5.5m.
Synergy Health, headquartered in Swindon, Wiltshire, says its European sterilisation business grew by 7% in the first half of 2010 and is operating at capacity in Germany, where it currently has one facility.
As well as assisting in the company’s efforts to break into the German decontamination market, the acquisition will complement existing plans to expand sterilisation capacity in Venlo, Netherlands, as well as building a new gamma facility in Marcoule, France.
Richard Steeves, chief executive of Synergy Health, said: “This acquisition builds on our position in Germany and opens up further opportunities in Eastern Europe. Germany could become a key market for Synergy and we are actively bidding for a number of decontamination contracts there.”
